Abstract
Kidney disease is widespread and endemic. It is estimated in its latest available statistics that 27 million people in the US have chronic kidney disease (United States Renal Data System 2012). Its extreme form, renal failure (ESRD) is diagnosed in 117,000 people in the US yearly.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abram, H. S., Moore, G. L., & Westervelt, B. S., Jr. (2001). Suicidal behavior in chronic dialysis patients. The American Journal of Psychiatry, 127, 1199–1204.
Baines, L. S., & Jindal, R. M. (2002). Loss of the imagined past: An emotional obstacle to medication compliance in kidney transplant recipients. Progress in Transplantation, 12, 305.
Baskin, J. (2009). Giving Until it Hurts? Altruistic donation of solid organs. The Journal of the American Academy of Psychiatry and the Law, 37, 377–379.
Bersani, G., Marino, P., Valeriani, G., Cuoco, V., Zitelli, C., Melcore C., Bersani, F.S. (2013). Manic-like psychosis associated with elevated through tacrolimus blood concentrations 17 years after kidney transplant. Case Reports in Psychiatry, 2013, 926395.
Brown, E. (2012). When and how should dialysis be discontinued? Non-dialysis therapy: A better policy than dialysis followed by withdrawal? Seminars in Dialysis, 25(1), 26–27.
Callaghan, J. T., Bergstrom, R. F., Ptak, J. R., & Beasley, C. M. (1999). Olanzapine pharmacokinetica and pharmacodynamic profile. Clinical Pharmacokinetics, 37, 177–193.
Carrasco, F.R., Moreno, A., Ridao, N., Calvo, N., Perez-Flores, I., Rodriguez, A., et al. (2009). Kidney transplantation complications related to psychiatric or neurological disorders. Transplantation Proceedings, 41(6), 2340–2342.
Carroll, B. T., Anfinson, T. J., Kennedy, J. C., Yendrek, R., Boutros, M., & Bilon, A. (1994). Catatonic disorder due to general medical conditions. Journal of Neuropsychiatry and Clinical Neurosciences, 6(2), 122–133.
Chandna, S., Da Silva-Gane, M., Marshall, C., Warwicker, P., Greenwood, R., & Farrington, K. (2011). Survival of elderly patients with Stage 5 CKD: Comparison of conservative management and renal replacement therapy. Nephrology, Dialysis, Transplantation, 26, 1608–1614.
Cohen, L. M., Germain, M. J., Woods, A. L., Mirot, A., & Burleson, J. A. (2005a). The family perspective of ESRD deaths. American Journal of Kidney Diseases, 45(1), 209–212.
Cohen, L. M., Germain, M. J., & Poppel, D. M. (2003). Perspectives on care at the close of life: Practical considerations in dialysis withdrawal: “To have that option is a blessing”. JAMA, 289, 2113–2119.
Cohen, L. M., Levy, N. B., Tessier, E., & Germain, M. (2005b). Renal disease. In J. A. Levenson (Ed.), Textbook of psychosomatic medicine (pp. 483–493). Washington, DC: American Psychiatric Press.
Cohen, L. M., McCue, J., Germain, M., & Woods, A. (1997). Denying the dying: Advance directives and dialysis discontinuation. Psychosomatics, 38(1), 27–34.
Cohen, L. M., Moss, A. H., Weisbord, S. D., & Germain, M. J. (2006). Renal palliative care. Journal of Palliative Med, 9(3), 975–990.
Cohen, L. M., Ruthazer, R., Moss, A. H., & Germain, M. J. (2010). Predicting six-month mortality for patients who are on maintenance hemodialysis. Clinical Journal of the American Society of Nephrology, 5(1), 72–79.
Corruble, E., Durrbach, A., Charpentier, B., Lang, P., Amidi, S., Dezamis, A., et al. (2010). Progressive increase of anxiety and depression in patients waiting for a kidney transplantation. Behavioral Medicine, 36(1), 32–36.
Cukor, D., Coplan, J., Brown, C., Friedman, S., Cromwell-Smkith, A., Peterson, R.A., et al. (2007). Depression and anxiety in urban hemodialysis patients. Clinical Journal of the American Society of Nephrology, 2, 484–490.
Cukor, D., Ver Halen N., Asher D. R., Coplan J. D., Weedon J., Wyka K. E., et al. (2013). Depression, quality of fife and fluid adherence are improved by psychosocial intervention: Results of a crossover trial in two urban hemodialysis centers. Journal of the American Society of Nephrology, 1–11.
Curran, C. F., Blahunka, P. C., & Lawrence, I. (1996). Acute overdoses of tacrolimus. Transplantation, 62(9), 1376–1377.
Davison, S. N. (2003). Pain in hemodialysis patients: Prevalence, cause, severity and management. American Journal of Kidney Diseases, 42(6), 1239–1247.
Davison, S. N. (2005). Chronic pain in end stage renal disease. Advances in Chronic Kidney Disease, 12(3), 326–334.
Davison, S. N., Chambers, E. J., & Ferro, C. J. (2010). Management of pain in renal failure. In E. J. Chambers, E. Brown, & M. Germain (Eds.), Supportive care for the renal patient (pp. 139–188). New York: Oxford University Press.
Davison, S. N., Cohen, L. M., & Germain, M. (2008). Palliative and supportive care. In S. W. Wilcox (Ed.), Therapy in nephrology & hypertension (A companion to Brenner & Rector’s the kidney 3rd ed., pp. 828–835). Philadelphia: Saunders Elsevier.
De Perrot, M., Spiliopoulos, A., Cottini, S., & Nicod, L. (2000). Ricou B (2000). Transplantation, 70(8), 1259–1260.
De Sousa, A. (2008). Psychiatric issues in renal failure and dialysis. Indian Journal of Nephrology, 47–50.
DeMartini, A., Dew, M. A., & Trzepacz, P. T. (2005). Organ transplantation. Focus, 3(2), 280–303.
DeMartini, A., Trzepacz, P. T., & Daviss, S. R. (1996). Prospective study of FK506 side effects: Anxiety or akathisia? Biological Psychiatry, 40(5), 407–411.
DSM-5 Washington, DC: American Psychiatric Press, 2013.
Fissell, R.B., Bragg-Gresham, J.L., Lopes, A.A., Cruz, J.M., Fukuhara, S., Asano, Y., et al. (2005). Factors associated with “do not resuscitate” orders and rates of withdrawal from hemodialysis in the international. DOPPS Kidney International, 68(3), 1282–1288.
Fraile, P., Garcia-Cosmes, P., Garcia, T., Corbacho, L., Alvarez, M., & Tabernero, J. M. (2009). Hypotension, as a consequence of the interaction between tacrolikmus and mirtazapine, in a patient with renal transplant. Nephrology, Dialysis, Transplantation, 24(6), 1999–2001.
Fukunishi, I., Sugawara, Y., Takayama, T., Makuuchi, M., Kawarasaki, H., & Surman, O. (2001). Psychiatric disorders before and after Living-related transplantation. Psychosomatics, 42, 337–343.
Ghanizadeh, A., Man soori, Y., Ashkani, H., Fallahzadeh, M.H., Derakhshan, A., Shokrpour, N., et al. (2009). Major depressive disorder in children and adolescents after renal transplantation. Transplantation Proceedings, 41(5), 1627–1629.
Gressel GM, Levy NB, Cohen LM. In: Fogel B, Greenberg D (eds.) Psychiatric care of the medical patient. New York: Oxford University Press, 2014 (in press).
Halen, N. V., Cukor, D., Constantiner, M., & Kimmel, P. L. (2012). Depression and mortality in end-stage renal disease 2012. Current Psychiatry Reports, 14(1), 36–44.
Hardoy, M. C., Zamboni, F., Mameli, L., & Calabrese, J. R. (2012). Self-injurious and aggressive behavior associated with a tacrolimus overdose. Psychosomatics, 53(6), 602–603.
Huang, C. E., & Huang, T. L. (2010). Intramuscular Lorazepam in catatonia in patients with acute renal failure: A report of two cases. Chang Gung Medical Journal, 33(1), 106–109.
Iliescu, E.A., Coo, H., McMurray, M.H., Meers, C.L., Quinn, M.M., Singer, M.A., et al. (2003). Quality of sleep and health-related quality of life in haemodialysis patients. Nephrology, Dialysis, Transplantation, 18(1), 126–132.
Inturrisi, C. E. (2002). Clinical pharmacology of opioids for pain. The Clinical Journal of Pain, 18(4), S3–S13.
Iwashige, T., Inoue, K., & Nakajima, T. (1990). Renal transplantation: Psychiatric aspects and interventions. Japanese Journal of Psychiatry and Neurology, 44(1), 7–18.
James, S. P., & Mendelson, W. B. (2004). The use of trazodone as a hypnotic: A critical review. Journal of Clinical Psychiatry, 65(6), 752–755.
Jantz, A. S., Patel, S. J., Suki, W. N., Knight, R. J., Bhimaraj, A., & Gaber, A. O. (2013). Treatment of acute tacrolimus toxicity with phenytoin in solid organ transplant recipients. Case Reports in Transplantation, 375263, 2090-6943.
Kalivas, K., & Bourgeois, J. (2008). Catatonia after liver and kidney transplantation. General Hospital Psychiatry, 31, 196–198.
Kim, M. U., Kim, S. Y., Son, S. M., & Park, Y. H. (2011). A case of tacrolimus-induced encephalopathy after kidney transplantation. Korean Journal of Pediatrics, 54(1), 40–44.
Kimmel, P. L., Cukor, D., Cohen, S. D., & Peterson, R. A. (2007). Depression in end-stage renal disease patients: A critical review. Advances in Chronic Kidney Disease, 14(4), 328–343.
Kimmel, P. L., Gavin, C., Miller, G., Mendelson, W. B., Wernli, I., & Neugarten, J. (1997). Disordered sleep and noncompliance in a patient with end-stage renal disease. Advances in Renal Replacement Therapy, 4(1), 55–67.
Kimmel, P. L., Weihs, K., & Peterson, R. A. (1993). Survival in hemodialysis patients: The role of depression. Journal of the American Society of Nephrology, 3, 12–27.
Krantz, M. J., Lewkowiez, L., Hays, H., Woodroffe, M. A., Robertson, A. D., & Mehler, P. S. (2002). Torsade de pointes associated with very-high-dose methadone. Annals of Internal Medicine, 137(6), 501–504.
Kurella, M., Covinsky, K. E., Collins, A. J., & Chertow, G. M. (2007). Octogenarians and nonagenarians starting dialysis in the United States. Annals of Internal Medicine, 146(3), 177–183.
Kurella, M., Goldstein, M., & Perez-Stable, E. (2010). Preferences for dialysis withdrawal and engagement in advance care planning within a diverse sample of dialysis patients. Nephrology, Dialysis, Transplantation, 25(1), 237–242.
Kurella, M., Kimmel, P. L., Young, B., & Chertow, G. (2005). Suicide in the United States end-stage renal disease program. Journal of the American Society of Nephrology, 16(3), 774–781.
Kurella, M., & Meier, D. (2013). Five policies to promote palliative care for patients with ESRD. Clinical Journal of the American Society of Nephrology, 8(10), 1783–1790.
Lam, Y. W., Banerji, S., Hatfield, C., & Talbert, R. L. (1997). Principles of drug administration in renal insufficiency. Clinical Pharmacokinetics, 32(1), 30–57.
Leo, R. J., Smith, B. A., & Mori, D. L. (2003). Guidelines for conducting a psychiatric evaluation of the unrelated kidney donor. Psychosomatics, 44, 452–460.
Levenson, J. L., & Olbrisch, M. E. (1993). Psychosocial evaluation of organ transplant candidates: A survey of process, criteria, and outcomes in heart, liver, and kidney transplantation. Psychosomatics, 34, 144–153.
Levy, N. B. (1973). Sexual adjustment to maintenance hemodialysis and renal transplantation: A national survey by questionnaire: Preliminary report. Transactions—American Society for Artificial Internal Organs, 19, 144–153.
Levy, N. B. (1989). Psychosomatik und konsultations/liaison-psychiatrrie: Ein ubaerblick. Der Nervenarzt, 60, 724–731.
Levy, N. B. (1994). Psychological aspects of renal transplantation. Psychosomatics, 35, 427–433.
Levy, N. B. (2000). Psychiatric considerations in primary medical care of the patient in renal failure. Advances in Renal Replacement Therapy, 7, 231–238.
Levy NB, Abram HS, Kemph JP, McKegney FP, Scribner BH. (1974). In: N.B. Levy (Ed.) Living or dying: Adaptation to hemodialysis (pp. 3–29). Springfield, IL: Charles C. Thomas.
Levy, N. B., & Wynbrandt, G. D. (1975). The quality of life on maintenance hemodialysis. Lancet, 1, 1328–1330.
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swaertz, M. S., Rosenheck, R. A., Perkins, D. O., et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209–1223.
Lopes, A., Frade, I. C., Teixeira, L., Oliveira, C., Almeida, M., Dias, L., et al. (2011). Depression and anxiety in living kidney donation: Evaluation of donors and recipients. Transplantation Proceedings, 43(1), 131–136.
Manitpisitkul, W., McCann, E., Lee, S., & Weir, M. R. (2009). Drug interactions in transplant patients: what everyone should know. Current Opinion in Nephrology and Hypertension, 18(5), 404–411.
Masters, W. H., & Johnson, V. E. (1970). Human sexual inadequacy. Boston: Little, Brown.
Mendelson, W. B., & Jain, B. (1995). An assessment of short-acting hypnotics. Drug Safety, 13(4), 257–270.
Merkus, M. P., Jager, K. J., Dekker, F. W., de Haan, R. J., Boeschoten, E. W., & Krediet, R. T. (1999). Physical symptoms and quality of life in patients on chronic dialysis: Results of the Netherlands cooperative study on adequacy of dialysis (NECOSAD). Nephrology, Dialysis, Transplantation, 14, 1163–1170.
Mori, D. L., Gallagher, P., & Milne, J. (2000). The structured interview for renal transplantation-SIRT. Psychosomatics, 41, 393–406.
Moss, A. H. (2001). Shared decision-making in dialysis: The new RPA/ASN guideline on appropriate initiation and withdrawal of treatment. American Journal of Kidney Diseases, 37(5), 1081–1091.
Mrvos, R., Hodgman, M., & Krenzelok, E. P. (1997). Tacrolimus (FK 506) overdose: A report of five cases. Journal of Toxicology—Clinical Toxicology, 35(4), 395–399.
Murtagh, F., & Weisbord, S. (2010). Symptoms in renal disease; their epidemiology, assessment and management. In E. J. Chambers, E. Brown, & M. Germain (Eds.), Supportive Care for the Renal Patient (pp. 103–138). New York: Oxford University Press.
Muslin, H. L. (1971). On acquiring a kidney. The American Journal of Psychiatry, 127, 1185–1188.
Neely, K. J., & Roxe, D. M. (2000). Palliative care/hospice and the withdrawal of dialysis. Journal of Palliative Medicine, 3(1), 57–67.
Nghiem, D. D. (2002). Role of Pharmacologic enhancement of p450 in cyclosporine overdose. Transplantation, 74(9), 1355–1356.
Nowak, M., Molnar, M.Z., Szeifert, L., Kovacs, A.Z., Vamos, E.P., Zoller, R., et al. (2010). Depressive symptoms and mortality in patients after kidney transplantation: A prospective prevalent cohort study. Psychosomatic Medicine, 72, 527–534.
Olbrisch, M. E., Levenson, J. L., & Hamer, R. (1989). The PACT: A rating scale for the study of clinical decision making in psychosocial screening of organ transplant candidates. Clinical Transplantation, 3, 1664–1669.
Parker, T. F. (1992). Trends and concepts in the prescription and delivery of dialysis in the United States. Seminars in Nephrology, 12, 267–275.
Pieta, J., Millar, T., Zacharias, J., Fine, A., & Kryger, M. (1998). Effect of pergolide on restless legs and leg movements in Sleep in Uremic Patients. Sleep, 21(6), 617–622.
Reichsman, F., & Levy, N. B. (1972). Adaptation to hemodialysis: A four-year study of 25 patients. Archives in Internal Medicine, 138, 859–865.
Renal Physicians Association (RPA), & American Society of Nephrology. (2010). Shared decision-making in the appropriate initiation of and withdrawal from dialysis, clinical practice guideline (2nd ed.). Washington, DC: RPA.
Rosenthal, A. D., Ver Halen, N., & Cukor, D. (2012). Depression and nonadherence predict mortality in hemodialysis treated end-stage renal disease patients. Hemodialysis International, 6(3), 387–393.
Rothschild, A. J. (1992). Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: A review of the literature. Journal of Clinical Psychiatry, 53(Suppl), 69–79.
Rowley, A. A., Hong, B. A., Martin, S., Jones, L., Vijayan, A., Shenoy, S., et al. (2009). Psychiatric disorders: Are they an absolute contraindication to living donation? Progress in Transplantation, 19(2), 128–131.
Rundell, J. R., & Hall, R. C. W. (1997). Psychiatric characteristics of consecutively evaluated outpatient renal transplant candidates and comparisons with consultation-liaison I\inpatients. Psychosomatics, 38, 269–276.
Russ, A., & Kaufman, S. (2012). Discernment rather than decision-making among elderly dialysis patients. Seminars in Dialysis, 25(1), 31–32.
Russ, A., Shim, J., & Kaufman, S. (2007). The value of ‘life at any cost’: Yalk about stopping kidney dialysis. Social Science and Medicine, 64(11), 2236–2247.
Schell, J., Da Silva-Gane, M., & Germain, M. (2013). Recent Insights into life expectancy with and without dialysis. Current Opinion in Nephrology and Hypertension, 22, 185–192.
Sein, A. J., Chodorowski, Z., & Kujawska, H. (2005). Acute suicidal intoxication with tacrolimus in a kidney transplant patient. Przeglad Lekarski, 62(6), 517–518.
Sekine, R., Obbes, E., Coyle, N., & Inturrisi, C. (2007). The successful use of parenteral methadone in a patient with prolonged QTc interval. Journal of Pain and Symptom Management, 34(5), 566–569.
Sketris, I. S., Onorato, L., Yatscoff, R. W., Givner, M., Nicol, D., & Abraham, I. (1993). Eight days of cyclosporine overdose: A case report. Pharmacotherapy, 13(6), 658–660.
Sloand, J. A., Shelly, M. A., Feigin, A., Bernstein, P., & Monk, R. D. (2004). A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. American Journal of Kidney Diseases, 43(4), 663–670.
Sugawara, H., Nishimura, K., Kobayashi, S., Ishida, H., Tanabe, K., & Ishigooka, J. (2008). Paradoxical depression in renal transplant recipients. Transplantation Proceedings, 40(10), 3448–3450.
Swidler, M. (2013). Considerations in starting a patient with advanced frailty on dialysis: Complex biology meets challenging ethics. Clinical Journal of the American Society of Nephrology, 8(8), 1421–1428.
Szeifert, L., Molnar, M.Z., Ambrus, C., Koczy, A.B., Kovacs, A.Z., Vamos, E.P., et al. (2010). Symptoms of depression in kidney transplant recipients: A cross-sectional study. American Journal of Kidney Diseases, 55(1), 132–140.
Timmerman, L., Zuidema, W.C., Erdman, R.A., Kranenberg, L.W., Timman, R., Ijzermans, J.N., et al. (2013). Psychological functioning of unspecified anonymous living kidney donors before and after donation. Transplantation, 95(11), 1369–1374.
Tsunoda, T., Yamashita, R., Kojima, Y., & Takahara, S. (2010). Risk factors for depression after kidney transplantation. Transplantation Proceedings, 42(5), 1679–1681.
Twillman, R. K., Manetto, C., Wellisch, D. K., & Wolcott, D. L. (1993). The transplant evaluation rating scale: A revision of the psychosocial levels system for evaluating organ transplant candidates. Psychosomatics, 34, 144–153.
United States Renal Data System. (2010). Excerpts from USRDS 2009 Annual Data Report. U.S. Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. American Journal of Kidney Diseases, 55(Suppl 1), S1.
United States Renal Data System. (2012). USRDS 2012 annual data report—Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute Diabetes and Digestive and Kidney Diseases.
Valderrqabano, F., Jofre, R., & Lopez-Gomez, J. M. (2001). Quality of life in end-stage renal disease patients. American Journal of Kidney Diseases, 38, 443–464.
Weisbord, S. D., Carmody, S. S., Bruns, F. J., Rotondi, A. J., Cohen, L. M., Zeidel, M. L., et al. (2003). Symptom burden, quality-of-life, advance care planning, and the potential value of palliative care in severely ill hemodialysis patients. Nephrology, Dialysis, Transplantation, 18, 1345–1352.
Werb, R. (2011). Palliative care in the treatment of end-stage renal failure. Primary Care, 38(2), 299–309.
Williams, A., Dwyer A., Eddy, A.A., Fink, J.C., Jaber, B.L., Linas, S.L., et al. (2012). Critical and honest conversations: The evidence behind the “choosing wisely” campaign recommendations by the American Society of Nephrology. Clinical Journal of the American Society of Nephrology, 7(10), 1664–1672.
Wong, E. H., Chan, N. N., & Sze, K. H. (2002). Serotonin syndrome in a renal transplant patient. Journal of the Royal Society of Medicine, 95(6), 304–305.
Zelle, D.M., Dorland, H.F., Rosmalen, J.G., Corpeleijn, E., Gans, R.O., Homan van der Heide, J.J., et al. (2012). Impact of depression on long-term outcome after renal transplantation: A prospective cohort study. Transplantation, 94(10), 1033–1040.
Zylber-Katz, E., Putterman, C., & Caraco, Y. (1994). Multiple drug overdose in a kidney transplant patient. Therapeutic Drug Monitoring, 16(3), 327–331.
Acknowledgement
Dr. Levy wishes to thank Drs. Daniel Cukor, Eli A. Friedman and Paul L. Kimmel for their help.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Hoyle Leigh & Jon Streltzer
About this chapter
Cite this chapter
Levy, N.B., Mirot, A. (2015). The Renal Dialysis and Kidney Transplant Patient. In: Leigh, H., Streltzer, J. (eds) Handbook of Consultation-Liaison Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-11005-9_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-11005-9_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11004-2
Online ISBN: 978-3-319-11005-9
eBook Packages: MedicineMedicine (R0)